According to the publisher, the global peripheral vascular devices market is expected to display a positive market trend over the estimated phase 2021-2028, while exhibiting a CAGR of 11.54%.
Factors such as the growing incidence of peripheral arterial disease (PAD) and the adoption of minimally-invasive procedures for its treatment are majorly boosting the growth of this market. However, the stringent regulatory processes and the intense rivalry among competitors are hampering the industry growth. On the bright side though, continuous advancement in technology presents numerous growth opportunities for the studied market. Also, developing nations are showing huge potential for growth, which is beneficial for market progress.
The Asia-Pacific is anticipated to showcase the fastest growth rate in the global market. Countries in this region offer lucrative opportunities for industry players. Also, factors such as increasing healthcare budgets and expanding disposable income are helping the market to grow further. Besides, a rise in the demand for advanced vascular devices, as a result of the rise in the geriatric population, is supplementing the growth of the peripheral vascular devices market.
Cardinal Health Inc is a Fortune 500 company providing healthcare services. Its specialization includes the distribution of medical products and pharmaceuticals, and it serves more than 100,000 locations. Cardinal Health completed the acquisition of Cordis in 2015, which was earlier a subsidiary of Johnson & Johnson. The INCRAFT AAA Stent Graft System, PRECISE PRO RX Stent, ANGIOGUARD RX Guidewire System, CORDIS Access Portfolio Diagnostic Guidewires, EMERALD Diagnostic Guidewire, AQUATRACK Hydrophilic Nitinol Guidewire, Guiding Catheters, and Steerable Guidewires are some of the products and systems offered by the company. Cardinal's health brand products are sold and distributed across North America, Europe, Asia, and other regions.
Factors such as the growing incidence of peripheral arterial disease (PAD) and the adoption of minimally-invasive procedures for its treatment are majorly boosting the growth of this market. However, the stringent regulatory processes and the intense rivalry among competitors are hampering the industry growth. On the bright side though, continuous advancement in technology presents numerous growth opportunities for the studied market. Also, developing nations are showing huge potential for growth, which is beneficial for market progress.
REGIONAL OUTLOOK
The global market for peripheral vascular devices spans across the regions of North America, the Asia-Pacific, Europe, Latin America, and the Middle East and Africa.The Asia-Pacific is anticipated to showcase the fastest growth rate in the global market. Countries in this region offer lucrative opportunities for industry players. Also, factors such as increasing healthcare budgets and expanding disposable income are helping the market to grow further. Besides, a rise in the demand for advanced vascular devices, as a result of the rise in the geriatric population, is supplementing the growth of the peripheral vascular devices market.
COMPETITIVE OUTLOOK
The companies competing in the peripheral vascular devices market include Terumo Interventional Systems Inc, Boston Scientific Corporation, Angioscore Inc (Spectranetics Corporation), Becton Dickinson and Company, Cardinal Health Inc (Cordis), Teleflex Medical, Medtronic Plc, Koninklijke Philips NV, Cook Group, Endologix, Edwards Lifesciences Corporation, and Abbott Laboratories.Cardinal Health Inc is a Fortune 500 company providing healthcare services. Its specialization includes the distribution of medical products and pharmaceuticals, and it serves more than 100,000 locations. Cardinal Health completed the acquisition of Cordis in 2015, which was earlier a subsidiary of Johnson & Johnson. The INCRAFT AAA Stent Graft System, PRECISE PRO RX Stent, ANGIOGUARD RX Guidewire System, CORDIS Access Portfolio Diagnostic Guidewires, EMERALD Diagnostic Guidewire, AQUATRACK Hydrophilic Nitinol Guidewire, Guiding Catheters, and Steerable Guidewires are some of the products and systems offered by the company. Cardinal's health brand products are sold and distributed across North America, Europe, Asia, and other regions.
Frequently Asked Questions about the Global Peripheral Vascular Devices Market
What is the estimated value of the Global Peripheral Vascular Devices Market?
What is the growth rate of the Global Peripheral Vascular Devices Market?
What is the forecasted size of the Global Peripheral Vascular Devices Market?
Who are the key companies in the Global Peripheral Vascular Devices Market?
Report Attribute | Details |
---|---|
No. of Pages | 192 |
Published | March 2021 |
Forecast Period | 2021 - 2028 |
Estimated Market Value ( USD | $ 3451.66 million |
Forecasted Market Value ( USD | $ 7414.83 million |
Compound Annual Growth Rate | 11.5% |
Regions Covered | Global |
Table of Contents
1. Global Peripheral Vascular Devices Market - Summary
2. Industry Outlook
3. Global Peripheral Vascular Devices Market Outlook – by Device Type
4. Global Peripheral Vascular Devices Market – Regional Outlook
5. Competitive Landscape
6. Methodology & Scope
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- Angioscore Inc (Spectranetics Corporation)
- Boston Scientific Corporation
- Becton Dickinson and Company
- Cook Group
- Cardinal Health Inc (Cordis)
- Edwards Lifesciences Corporation
- Endologix
- Koninklijke Philips Nv
- Medtronic plc
- Teleflex Medical
- Terumo Interventional Systems Inc